Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Crinetics Pharmaceuticals, Inc. (CRNX)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Jun-05-23 | Mar-31-23 | Dec-05-22 | Sep-30-22 | Sep-05-22 | Jun-30-22 | Jun-05-22 |
| | 10-Q | 8-K | 10-Q | 8-K | 10-Q | 8-K | 10-Q | 8-K |
| Revenues | | | 100.0% | | 100.0% | | 100.0% | |
| Cost of goods sold | | | 116.9% | | 117.5% | | 0.0% | |
| Gross profit | | | -16.9% | | 100.0% | | 100.0% | |
| Selling, general and administrative | | | 361.8% | | 3880.8% | | 3927.6% | |
| Depreciation | | | 1.8% | | 23.3% | | 25.9% | |
| EBIT | | | -420.8% | | -404.3% | | -3804.8% | |
| Pre-tax income | | | -315.7% | | -289.9% | | -3799.6% | |
| Income taxes | | | 0.0% | | 0.0% | | 0.0% | |
| Net income | | | -315.7% | | -289.9% | | -3799.6% | |
|